Vienna, Austria

Ian Livey


 

 

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 1996-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Ian Livey: Innovator in Lyme Disease Vaccine Development

Introduction

Ian Livey is a prominent inventor based in Vienna, Austria, known for his significant contributions to the field of vaccine development. With a total of 11 patents to his name, Livey has focused on innovative solutions to combat Lyme disease, a condition caused by the bacterium Borrelia, which is transmitted through tick bites. His work has the potential to greatly impact public health by providing effective preventive measures against this disease.

Latest Patents

One of Ian Livey's latest patents is titled "Chimeric OspA genes, proteins and methods of use thereof." This invention pertains to the development of chimeric OspA molecules intended for use in a new Lyme vaccine. The chimeric OspA molecules consist of the proximal portion from one OspA serotype combined with the distal portion from another OspA serotype, while maintaining the antigenic properties of both parent polypeptides. These molecules can be delivered alone or in combination to offer protection against various genospecies. Additionally, the invention outlines methods for administering these chimeric OspA molecules to subjects for the prevention and treatment of Lyme disease or borreliosis.

Career Highlights

Throughout his career, Ian Livey has worked with notable companies such as Baxalta GmbH and Brookhaven Science Associates, LLC. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Ian Livey has had the opportunity to work alongside esteemed colleagues, including Brian A. Crowe and Maria O'Rourke. These collaborations have enriched his research and have been instrumental in advancing his innovative projects.

Conclusion

Ian Livey stands out as a key figure in the development of vaccines for Lyme disease, with his innovative chimeric OspA molecules paving the way for new preventive strategies. His extensive patent portfolio and collaborative efforts highlight his commitment to improving public health through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…